← Back to feedRead original →
VERIFIEDET Finance·neutral
Sun will require HC nod for Semaglutide tablet launch
AI Summary
- ·Sun Pharma Laboratories must obtain Delhi High Court approval before launching semaglutide tablets.
- ·This directive follows a patent infringement plea filed by Novo Nordisk.
- ·The court has requested Sun Pharma's response regarding Novo Nordisk's patent protection claim for the tablet formulation.